# Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection

> **NCT04363632** · — · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 1231 (actual)

## Conditions studied

- Sars-CoV2
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04363632
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-02
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 1231 (ACTUAL)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04363632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04363632, "Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04363632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*